1A8 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Accelerate Diagnostics Inc

Watchlist Manager

Watchlist

Price: 6.35 EUR 1.6%

Market Cap: €416.6m

A	Accelerate Diagnostics Inc XBER:1A8	US
H	HSBC Holdings PLC SWB:HBC1	UK
C	Conocophillips SWB:YCP	US

Profitability Summary

Accelerate Diagnostics Inc's profitability score is 37/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

23%

Sustainable 3Y Average Gross Margin

28%

Declining Gross Margin

28% > 23%

Negative Operating Margin

-302%

Negative 3Y Average Operating Margin

-411%

Operating Margin is Increasing

-500% > -302%

Negative Net Margin

-428%

Negative 3Y Average Net Margin

-485%

Net Margin is Increasing

-522% > -428%

Negative Free Cash Flow Margin

-211%

Negative 3Y Average Free Cash Flow Margin

-304%

Free Cash Flow Margin is Increasing

-394% > -211%

Exceptional ROE

132%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-377%

ROIC is Increasing

-382% > -340%

View All

Hide

Collapse

37 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.